Zobrazeno 1 - 2
of 2
pro vyhledávání: '"I-Shih Tsai"'
Autor:
Shu-Fen Yen, Ching-Kuo Lee, Shu Huei Kao, Yu Min Kuo, Fu-Yen Chang, Thi Huong Ngo, Hsien-Tsung Lu, Fang-Yu Tu, Shihua Li, Yi-Hua Tsai, Yung-Feng Lin, Xiao-Jiang Li, I-Shih Tsai, Lai-Lei Ting
Publikováno v:
Molecular Neurobiology. 56:7572-7582
A hallmark of Alzheimer's disease (AD) pathogenesis is the accumulation of extracellular plaques mainly composed of amyloid-β (Aβ) derived from amyloid precursor protein (APP) cleavage. Recent reports suggest that transport of APP in vesicles with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f78c4f6f865b595603ff69fc2380e35
https://doi.org/10.1007/s12035-019-1587-1
https://doi.org/10.1007/s12035-019-1587-1
Autor:
Jau-Jiuan Sheu, I-Shih Tsai, Ching-Kuo Lee, Ching-Yu Lin, I-Uen Hsu, Horng Mo Lee, Li-Yu Yang, Hui-Wen Chang, Shu Huei Kao, Chien-Ho Chen, Sen-Te Wang, Yung-Feng Lin
Publikováno v:
Clinical Biochemistry. 56:75-82
Objective Advanced glycation end products (AGEs) are involved in the pathogenesis of Alzheimer's disease (AD). Specific AGEs and related autoantibodies may be early AD markers. Apolipoprotein A1 (ApoA1) and its post-translational modifications (PTMs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9139eab82ae3fd8c067b3f0066bd35f0
https://doi.org/10.1016/j.clinbiochem.2018.04.009
https://doi.org/10.1016/j.clinbiochem.2018.04.009